Skip to main content

Table 3 Parameter estimates predicting overexpression from histology

From: Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways

   OR 95% CI P Wald chi-square
BCRP Carcinoma and serous 2.21 .88-5.58 0.09 8.39, p = .039
  Clear cell 2.2 .49-9.94 0.3  
  Endometriod 0.735 .22-2.41 0.61  
ER Carcinoma and serous 1.39 .63-3.05 0.42 7.76, p = .051
  Clear Cell 0.26 .06-1.09 0.07  
  Endometriod 1.55 .54-4.46 0.42  
MGMT Carcinoma and serous 1.64 .46-5.81 0.48 18.57, p < .001
  Clear cell 0.2 .04-.86 0.03  
  Endometriod 1.56 .24-10.14 0.64  
PTEN Carcinoma and serous 1.19 .54-2.61 0.67 7.01, p = .071
  Clear cell 0.59 .19-1.85 0.36  
  Endometriod 0.49 .17-1.41 0.18  
RRM1 Carcinoma and serous 0.67 .31-1.46 0.32 13.06, p = .005
  Clear cell 0.13 .03-.52 0.004  
  Endometriod 0.25 .08-.78 0.017